If you're one of the 65 million Americans said to rely on this drug, you'll want to see if your prescription's been impacted.

A pharmaceutical company is recalling a blood pressure medication due to a potential cancer risk, the FDA announced this week. Aurobindo Pharma USA is recalling two lots of quinapril and ...

Two lots of Aurobindo's 20 mg/12.5 mg are included in the recall, both with expiration dates through January 2023, and the specific lot numbers can be found in the recall announcement on Oct. 25.

Granules India is recalling more than 33,000 bottles of a generic blood pressure lowering medication from US shelves due to ...

Indian drugmaker Granules has issued a voluntary recall of more than 33,000 bottles of the generic high blood pressure treatment metoprolol succinate, citing the drug's failure to meet dissolution ...

Lupin Pharmaceuticals Inc. is recalling four lots of its blood pressure medication, ... FDA recalls blood pressure medication over cancer risks by Maureen Breslin - 12/27/22 10:49 AM ET.

A blood pressure medication has been recalled due to an increase in risk of cancer if ... The FDA advises anyone with questions on the recall to call Inmar Rx Solutions at 877-538-8445, from ...

A second pharmaceutical company has recalled a blood pressure medication that could increase the risk of cancer if taken in large amounts, the U.S. Food and Drug Administration announced last week ...

The Hyderabad-based drug maker is recalling 33,024 bottles of Metoprolol Succinate extended-release tablets in 100 count and ...

NRA-Amlodipine 5 mg, DIN 02476460. Issue: Health products - Product safety. What to do: Check your bottle of NRA-Amlodipine 5 mg ...

Granules India recalls 33,000 bottles of Metoprolol Succinate due to manufacturing issues. The US FDA initiated a Class II recall.